Health & Wellness

Lucira COVID-19 All-In-One Test Kit: US FDA Authorises First Coronavirus Diagnostic Test For Self-Testing at Home, Check Details

Chapare Virus, Capable of Human-to-Human Transmission, Found in Bolivia: What Are The Symptoms? Can It Spread Akin to COVID-19?

Moderna CEO Says COVID-19 Vaccine's 'Several Million Doses' Ready in US, Warns Europe of 'Slow Deliveries' if Contract Signings Delayed

Mouthwash Can 'Kill COVID-19 Virus Within 30 Seconds in Lab', Finds Cardiff University Study

Measles Outbreaks Likely in Wake of COVID-19 Pandemic, Say Scientists

Teen with PENIS Gets Pregnant: Recent Routine Test Finds Working Ovaries, Uterus, Cervix & Fallopian Tubes in Person Born with Male Genitals! What Is Persistent Mullerian Duct Syndrome (PMDS)?

India's Daily COVID-19 Recoveries Continue to Exceed Daily Cases

COVID-19 Vaccines, Developed by Russia, Have Shown More Than 90% Effectiveness But All Patients' Immune Response Not Same, Says Health Minister

Moderna COVID-19 Vaccine: 6 Things You Didn't Know About the Coronavirus Vaccine That Has Reportedly Proven Over 94% Efficacy

1 Year Since Coronavirus Outbreak: First Case of COVID-19 Traced Back to November 17, 2019 in China's Hubei Province

World Prematurity Day 2020 Date and Significance: Know the History and Events Organised to Create Awareness About Preterm Birth

Obese People Found to Be at Increased Risk of COVID-19

Moderna COVID-19 Vaccine, Which Showed 94.5% Efficacy in Phase 3 Trials, Remains ‘Stable’ at 2–8 Degrees Celsius for 30 Days

COVID-19 Vaccine: White House Says 'Big Wins for All' as Pfizer, Moderna Announce Positive Results

Dr AM Arun, Founder of Vasan Eye Care, Dies Due to Cardiac Arrest at Age of 51

COVID-19 Spread Easier in Indoors Than Outdoors, Winter Perfect Set-up for Contagion, Says Indian-American Advisor Dr Vivek Murthy

Covaxin: Bharat Biotech's COVID-19 Vaccine into Phase-3 Trials

COVID-19 Vaccine Update: Johnson & Johnson Begins Phase 3 of Two-Dose Trials of Its Vaccine

Moderna COVID-19 Vaccine 94.5% Effective in Phase 3 Trials, Likely to Receive Emergency Use Approval From US FDA

Antibiotics Before Age 2 Associated with Childhood Health Issues, Finds Study

Categories